Getein Biotech Inc. logo

Getein Biotech Inc. (603387)

Market Closed
11 Aug, 06:57
SSE SSE
¥
9. 20
-0.12
-1.2876%
¥
4.29B Market Cap
- P/E Ratio
0.36% Div Yield
10.92M Volume
- Eps
¥ 9.32
Previous Close
Add Transaction
Day Range
9.18 9.41
Year Range
7.37 11.42
Want to track 603387 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603387 closed today lower at ¥9.2, a decrease of -1.2876% from yesterday's close, completing a monthly increase of 22.178% or ¥1.67. Over the past 12 months, 603387 stock gained 9.5238%.
603387 pays dividends to its shareholders, with the most recent payment made on Jun 18, 2026. The next estimated payment will be in In 4 months on Dec 18, 2026 for a total of ¥0.15.
The last earnings report, released on May 22, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Getein Biotech Inc. has completed 4 stock splits, with the recent split occurring on Jun 08, 2022.
The company's stock is traded on one exchange.

603387 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Getein Biotech Inc. (603387) FAQ

What is the stock price today?

The current price is ¥9.20.

On which exchange is it traded?

Getein Biotech Inc. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603387.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.36%.

What is its market cap?

As of today, the market cap is 4.29B.

Has Getein Biotech Inc. ever had a stock split?

Getein Biotech Inc. had 4 splits and the recent split was on Jun 08, 2022.

Getein Biotech Inc. Profile

Biotechnology Industry
Healthcare Sector
Mr. Gang Zhu CEO
SSE Exchange
CNE100002RR9 ISIN
CN Country
- Employees
18 Jun 2026 Last Dividend
1 Jun 2018 Last Split
- IPO Date

Overview

Getein Biotech, Inc. is a prominent entity in the biotechnology industry, focused on the research, development, production, and international sales of in vitro diagnostic reagents and instruments. Since its inception in 2002, the company has established its headquarters in Nanjing, China, and has made significant strides not only within domestic markets but on an international scale as well. Getein Biotech is dedicated to advancing medical diagnosis through innovation, offering a wide range of diagnostic solutions that cater to various fields such as cardiovascular diseases, inflammation, kidney functions, and more. Its comprehensive approach in providing quality diagnostic products and services addresses the needs of various healthcare settings, ranging from laboratory departments and emergency rooms to health examination centers and home health management.

Products and Services

Getein Biotech, Inc. boasts a diverse portfolio of diagnostic products and services, including but not limited to:

  • Cardiac Troponin I Detection: Providing point-of-care testing solutions for rapid diagnosis of myocardial infarctions through the measurement of cardiac troponin I.
  • Chemiluminescence: Advanced technology for highly sensitive and specific immunoassays, used in various fields such as hormone, tumor markers, and infectious diseases detection.
  • Biochemical Detection: Comprehensive range of tests for the quantitative and qualitative analysis of biological samples, essential in evaluating and monitoring general health, organ function, and metabolic state.
  • Molecular Detection: Cutting-edge solutions for the identification of pathogens and genetic markers, enabling precision medicine and targeted therapy.
  • Thrombus and Hemostasis Detection: Specialized tests to assess blood clotting mechanisms and diagnose disorders related to thrombosis and bleeding abnormalities.
  • Blood Cell Analysis Detection: Instruments and reagents for the examination of blood cell count and properties, critical in diagnosing and monitoring hematological diseases.
  • Urine Analysis: Automated and manual testing products for the assessment of kidney function, urinary tract infections, and other metabolic conditions.
  • Quality Control Products: A range of products designed to ensure the accuracy and reliability of laboratory test results through consistent performance checks.
  • Diagnostic Raw Materials: High-quality materials and reagents for use in the development and manufacturing of diagnostic assays and products.

These products and services span across various technical fields and detection areas, including cardiovascular, inflammation, kidney diseases, thyroid function, hormone levels, glucose metabolism, tumors, blood cells, blood coagulation, and more. Their applications are widespread, serving the laboratory departments of medical institutions, emergency rooms, health examination centers, community clinics, and even for personal health management at home.

Contact Information

Address: No.9 Bofu Road, Nanjing, China, 211505
Phone: 86 25 6856 8588